Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03775486
Title Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION) (ORION)
Acronym ORION
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | HUN | GBR | BEL

Facility Status City State Zip Country Details
Research Site Bonita Springs Florida 34135 United States Details
Research Site Saint Petersburg Florida 33705 United States Details
Research Site Tallahassee Florida 32308-5304 United States Details
Research Site West Palm Beach Florida 33401 United States Details
Research Site Kansas City Missouri 64132 United States Details
Research Site Bethlehem Pennsylvania 18015 United States Details
Research Site Chattanooga Tennessee 37404 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77090 United States Details
Research Site Aalst 9300 Belgium Details
Research Site Leuven 3000 Belgium Details
Research Site Roeselare 8800 Belgium Details
Research Site Budapest 1088 Hungary Details
Research Site Budapest 1122 Hungary Details
Research Site Debrecen 4032 Hungary Details
Research Site Deszk 6772 Hungary Details
Research Site Farkasgyepü 8582 Hungary Details
Research Site Törökbálint 2045 Hungary Details
Research Site Ahmedabad 380009 India Details
Research Site Ahmedabad 380053 India Details
Research Site Jamnagar 361008 India Details
Research Site Kochi 682026 India Details
Research Site Mysuru 570021 India Details
Research Site Nashik 422004 India Details
Research Site Nashik 422005 India Details
Research Site Pune 411001 India Details
Research Site Thiruvananthapuram 695011 India Details
Research Site Chuo-ku 104-0045 Japan Details
Research Site Kanazawa-shi 920-8641 Japan Details
Research Site Kurume-shi, 830-0011 Japan Details
Research Site Matsuyama-shi 791-0280 Japan Details
Research Site Nagoya-shi 460-0001 Japan Details
Research Site Sendai-shi 980-0873 Japan Details
Research Site Sunto-gun 411-8777 Japan Details
Research Site Ube-shi 755-0241 Japan Details
Research Site Dongjakgu 07061 Korea, Republic of Details
Research Site Goyang-si 10408 Korea, Republic of Details
Research Site Seodaemun-gu 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Suweonsi Paldalgu 16247 Korea, Republic of Details
Research Site Chihuahua 31200 Mexico Details
Research Site Culiacan 80230 Mexico Details
Research Site San Luis Potosí 78250 Mexico Details
Research Site Blaricum 1261 Netherlands Details
Research Site Harderwijk 3844 Netherlands Details
Research Site Tilburg 5022 GC Netherlands Details
Research Site Białystok 15-540 Poland Details
Research Site Poznan 60-693 Poland Details
Research Site Prabuty 82-550 Poland Details
Research Site Łódź 90-302 Poland Details
Research Site Arkhangelsk 163045 Russian Federation Details
Research Site Chelyabinsk 454092 Russian Federation Details
Research Site Kursk 305524 Russian Federation Details
Research Site Moscow 115478 Russian Federation Details
Research Site Nal'chik 360000 Russian Federation Details
Research Site P. Herzen Moscow Oncology Rese 125284 Russian Federation Details
Research Site Sochi 354000 Russian Federation Details
Research Site St. Petersburg 197022 Russian Federation Details
Research Site Yaroslavl 150054 Russian Federation Details
Research Site Dnipro 49102 Ukraine Details
Research Site Kharkiv Region 61024 Ukraine Details
Research Site Kirovohrad 25006 Ukraine Details
Research Site Odesa 65055 Ukraine Details
Research Site Uzhhorod 88000 Ukraine Details
Research Site Zaporizhzhia 69059 Ukraine Details
Research Site Dundee DD1 9SY United Kingdom Details
Research Site Hull HU6 7RX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field